Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 26, 2017

DrugPatentWatch Database Preview

MEROPENEM Drug Profile

« Back to Dashboard

What is the patent landscape for Meropenem, and what generic alternatives are available?

Meropenem is a drug marketed by Sandoz, Acs Dobfar, Aurobindo Pharma Ltd, Par Sterile Products, Hospira Inc, Gland Pharma Ltd, Daewoong Pharm Co, Amneal Pharms, Savior Lifetec Corp, and B Braun Medical Inc. and is included in ten NDAs.

The generic ingredient in MEROPENEM is meropenem. There are thirty-one drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the meropenem profile page.

Summary for Tradename: MEROPENEM

Patents:0
Applicants:10
NDAs:10
Suppliers / Packagers: see list10
Bulk Api Vendors: see list52
Clinical Trials: see list28
Patent Applications: see list3,914
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MEROPENEM at DailyMed

Pharmacology for Tradename: MEROPENEM

Ingredient-typeCarbapenems
Drug ClassPenem Antibacterial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz
MEROPENEM
meropenem
INJECTABLE;INJECTION091201-002Mar 29, 2011APRXNoNo► Subscribe► Subscribe
Savior Lifetec Corp
MEROPENEM
meropenem
INJECTABLE;INJECTION206086-001Apr 19, 2016APRXNoNo► Subscribe► Subscribe
Par Sterile Products
MEROPENEM
meropenem
INJECTABLE;INJECTION204139-002Jun 9, 2016APRXNoNo► Subscribe► Subscribe
Acs Dobfar
MEROPENEM
meropenem
INJECTABLE;INJECTION091404-001Oct 26, 2011APRXNoNo► Subscribe► Subscribe
Gland Pharma Ltd
MEROPENEM
meropenem
INJECTABLE;INJECTION206141-001Jun 8, 2016APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot